RALEIGH, NC—August 21, 2013—Clinverse, Inc., a global technology and eclinical commerce network for clinical trials, announced today the addition of Denis Connaghan
as Chief Executive Officer. Denis brings more than 25 years of
substantial commercialization experience across industry sectors
including technology, healthcare, insurance, life sciences and IT.
Prior to joining Clinverse, Denis served as a management consultant
and in interim executive roles at GMA Healthcare, Infina Connect and
several other life science IT and services companies. Additionally, he
served as the CEO of etrials Worldwide, an eclinical solutions provider
to pharmaceutical companies, prior to its acquisition by Merge
Healthcare.
“I’m thrilled to join such a fast-paced, growing company,” expressed
Connaghan. “Clinverse’s FLS platform is an industry-first and continues
to outpace the industry in terms of innovation. We are well positioned
to build on this solid technology foundation, and I look forward to
working with the Clinverse team to capitalize on my global and industry
expertise to drive additional opportunities in the clinical trial
services market.”
With the announcement of Denis as CEO, Tim Immel,
founder and former CEO of Clinverse, will take on the role of Chief
Product Officer. In his new position, Tim will dedicate 100 percent of
his commitment and direct attention to pursuing product excellence and
ensuring the company maintains and grows its undisputed lead in the area
of financial lifecycle systems for the clinical trials industry.
“Of all the many responsibilities I have had at Clinverse, none has
been more important to the business or more gratifying to me personally
than to design and build the exceptional products and services that we
offer, products that fill an important yet unmet need in the
marketplace,” said Immel. “Denis’s leadership is critical to our
long-term success as we continue taking Clinverse to the heights we all
envision, while delivering the highest quality service to clients.”
About Clinverse, Inc.
Clinverse, Inc. is a global technology and financial services company
that delivers highly secure, cloud-based financial management and
payment solutions for the clinical trials industry. Founded in 2008 and
headquartered in Raleigh, NC, the company delivers clinical financial
solutions through the only truly collaborative and transparent financial
management and payment platform. Used by leading BioPharma companies,
Clinverse has developed ClinPay®, a fully-configurable, game-changing
SaaS-based platform which manages tens of millions of dollars in
financial transactions for thousands of global sites while supporting
payments in 140 different currencies. For more information, please visit
www.clinverse.com.
Media Contact:
Molly Thompson, Crossroads PR, for Clinverse
919.821.2822
clinverse@crossroadspr.com
No comments:
Post a Comment